261 related articles for article (PubMed ID: 28602918)
1. Angiogenic and angiostatic factors in renal scleroderma-associated vasculopathy.
Gigante A; Navarini L; Margiotta D; Amoroso A; Barbano B; Cianci R; Afeltra A; Rosato E
Microvasc Res; 2017 Nov; 114():41-45. PubMed ID: 28602918
[TBL] [Abstract][Full Text] [Related]
2. Prediction of organ involvement in systemic sclerosis by serum biomarkers and peripheral endothelial function.
Kawashiri SY; Nishino A; Igawa T; Takatani A; Shimizu T; Umeda M; Fukui S; Okada A; Suzuki T; Koga T; Iwamoto N; Ichinose K; Tamai M; Nakashima M; Mizokami A; Matsuoka N; Migita K; Ogawa F; Ikeda S; Maemura K; Nakamura H; Origuchi T; Maeda T; Kawakami A
Clin Exp Rheumatol; 2018; 36 Suppl 113(4):102-108. PubMed ID: 29652651
[TBL] [Abstract][Full Text] [Related]
3. Different contributions of angiostatin and endostatin in angiogenesis impairment in systemic sclerosis: a cohort study.
Almeida I; Oliveira Gomes A; Lima M; Silva I; Vasconcelos C
Clin Exp Rheumatol; 2016; 34 Suppl 100(5):37-42. PubMed ID: 26885625
[TBL] [Abstract][Full Text] [Related]
4. Associations between circulating endostatin levels and vascular organ damage in systemic sclerosis and mixed connective tissue disease: an observational study.
Reiseter S; Molberg Ø; Gunnarsson R; Lund MB; Aalokken TM; Aukrust P; Ueland T; Garen T; Brunborg C; Michelsen A; Abraityte A; Hoffmann-Vold AM
Arthritis Res Ther; 2015 Aug; 17(1):231. PubMed ID: 26315510
[TBL] [Abstract][Full Text] [Related]
5. Serum uric acid as a marker of microvascular damage in systemic sclerosis patients.
Gigante A; Barbano B; Barilaro G; Quarta S; Gasperini ML; Di Mario F; Romaniello A; Amoroso A; Cianci R; Rosato E
Microvasc Res; 2016 Jul; 106():39-43. PubMed ID: 27003713
[TBL] [Abstract][Full Text] [Related]
6. Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers.
Distler O; Del Rosso A; Giacomelli R; Cipriani P; Conforti ML; Guiducci S; Gay RE; Michel BA; Brühlmann P; Müller-Ladner U; Gay S; Matucci-Cerinic M
Arthritis Res; 2002; 4(6):R11. PubMed ID: 12453314
[TBL] [Abstract][Full Text] [Related]
7. Intrarenal hemodynamic parameters correlate with glomerular filtration rate and digital microvascular damage in patients with systemic sclerosis.
Rosato E; Gigante A; Barbano B; Cianci R; Molinaro I; Rossi C; Massa R; Amoroso A; Pisarri S; Salsano F
Semin Arthritis Rheum; 2012 Jun; 41(6):815-21. PubMed ID: 22192932
[TBL] [Abstract][Full Text] [Related]
8. Dysregulation of angiogenic homeostasis in systemic sclerosis.
Farouk HM; Hamza SH; El Bakry SA; Youssef SS; Aly IM; Moustafa AA; Assaf NY; El Dakrony AH
Int J Rheum Dis; 2013 Aug; 16(4):448-54. PubMed ID: 23992267
[TBL] [Abstract][Full Text] [Related]
9. Impaired angiogenesis as a feature of digital ulcers in systemic sclerosis.
Silva I; Almeida C; Teixeira A; Oliveira J; Vasconcelos C
Clin Rheumatol; 2016 Jul; 35(7):1743-51. PubMed ID: 26920752
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of serum soluble Tie1 levels in patients with systemic sclerosis.
Noda S; Asano Y; Aozasa N; Akamata K; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Sumida H; Kuwano Y; Yanaba K; Tada Y; Sugaya M; Kadono T; Sato S
Arch Dermatol Res; 2013 May; 305(4):325-31. PubMed ID: 23233281
[TBL] [Abstract][Full Text] [Related]
11. Decreased ratio of circulatory vascular endothelial growth factor to endostatin in patients with systemic sclerosis--association with pulmonary involvement.
Dziankowska-Bartkowiak B; Waszczykowska E; Dziankowska-Zaboroszczyk E; de Graft-Johnson JE; Zalewska A; Łuczyńska M; Nowak D
Clin Exp Rheumatol; 2006; 24(5):508-13. PubMed ID: 17181918
[TBL] [Abstract][Full Text] [Related]
12. Serum apelin levels: clinical association with vascular involvements in patients with systemic sclerosis.
Aozasa N; Asano Y; Akamata K; Noda S; Masui Y; Yamada D; Tamaki Z; Tada Y; Sugaya M; Kadono T; Sato S
J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):37-42. PubMed ID: 22112232
[TBL] [Abstract][Full Text] [Related]
13. Correlation of endostatin and tissue inhibitor of metalloproteinases 2 (TIMP2) serum levels with cardiovascular involvement in systemic sclerosis patients.
Dziankowska-Bartkowiak B; Waszczykowska E; Zalewska A; Sysa-Jedrzejowska A
Mediators Inflamm; 2005 Aug; 2005(3):144-9. PubMed ID: 16106100
[TBL] [Abstract][Full Text] [Related]
14. In systemic sclerosis, microvascular and hands digital arteries damage correlates with serum levels of endostatin.
Gigante A; Navarini L; Margiotta D; Barbano B; Afeltra A; Rosato E
Microcirculation; 2018 May; 25(4):e12449. PubMed ID: 29537711
[TBL] [Abstract][Full Text] [Related]
15. Serum heparanase levels: A protective marker against digital ulcers in patients with systemic sclerosis.
Wu CY; Asano Y; Taniguchi T; Sato S; Yu HS
J Dermatol; 2015 Jun; 42(6):625-8. PubMed ID: 25808574
[TBL] [Abstract][Full Text] [Related]
16. Correlations between skin blood perfusion values and nailfold capillaroscopy scores in systemic sclerosis patients.
Ruaro B; Sulli A; Pizzorni C; Paolino S; Smith V; Cutolo M
Microvasc Res; 2016 May; 105():119-24. PubMed ID: 26907637
[TBL] [Abstract][Full Text] [Related]
17. Serum omentin levels: A possible contribution to vascular involvement in patients with systemic sclerosis.
Miura S; Asano Y; Saigusa R; Yamashita T; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Tamaki Z; Tada Y; Sugaya M; Sato S; Kadono T
J Dermatol; 2015 May; 42(5):461-6. PubMed ID: 25766303
[TBL] [Abstract][Full Text] [Related]
18. Brachial artery endothelial-dependent flow-mediated dilation identifies early-stage endothelial dysfunction in systemic sclerosis and correlates with nailfold microvascular impairment.
Rollando D; Bezante GP; Sulli A; Balbi M; Panico N; Pizzorni C; Negrini S; Brunelli C; Barsotti A; Cutolo M; Indiveri F; Ghio M
J Rheumatol; 2010 Jun; 37(6):1168-73. PubMed ID: 20436078
[TBL] [Abstract][Full Text] [Related]
19. Endothelial Dysfunction and Nailfold Videocapillaroscopy Pattern as Predictors of Digital Ulcers in Systemic Sclerosis: a Cohort Study and Review of the Literature.
Silva I; Teixeira A; Oliveira J; Almeida I; Almeida R; Águas A; Vasconcelos C
Clin Rev Allergy Immunol; 2015 Oct; 49(2):240-52. PubMed ID: 26142066
[TBL] [Abstract][Full Text] [Related]
20. Renal Parenchymal Thickness in Patients with Systemic Sclerosis Is Related to Intrarenal Hemodynamic Variables and Raynaud Renal Phenomenon.
Gigante A; Barbano B; Gasperini ML; Zingaretti V; Cianci R; Rosato E
J Rheumatol; 2020 Apr; 47(4):567-571. PubMed ID: 31203218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
